Identify and mitigate cybersecurity risks early on, US FDA tells device sponsors

Medical device makers should consider cybersecurity risks as part of the design and development of their product, and include in their marketing applications any risks identified and an explanation of how they plan to mitigate them, recommends the US Food and Drug Administration1,2.

More from Archive

More from Medtech Insight